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Abstract
The prevalence of cognitive impairments in the older adult population is growing. Finding
treatment solutions to impede a cognitive decline can possibly lead to fewer cases of mild
cognitive impairment, dementia, and Alzheimer’s disease. A Visual Paired Comparison (VPC)
could serve as a tool to predict, monitor, and regulate people who are susceptible to a cognitive
decline. The purpose of this study was to 1) to determine the validity of the Neurotrack 5-minute
VPC test with the Neurotrack 30-minute VPC test, 2) to determine the test-retest reliability of the
Neurotrack 5-minute VPC test, 3) to compare Neurotrack 5-minute VPC scores between
individuals with cognitive impairment (Mild Cognitive Impairment and/or Alzheimer's Disease)
to cognitively intact adults, 4) lastly to compare Neurotrack VPC results with other cognitive
tasks (MoCA, NIH toolbox, Dual task) performed within the study. This study included older
adults age 60+ split into cognitively intact individuals and cognitively impaired individuals
based from the MoCA. Analysis was ran on 28 subject in which 11 were cognitively impaired
(mean=.687; Std=.137) and 17 were cognitively intact (mean=.851; Std=.044). The relationship
between 5-minute VPC and the 30-minute VPC revealed a positive associations for both the first
(r=.504; p=.006) and second (r=.420; p=.019) time points/trials. No significant differences
between the 2 time points/trials (p=.212) which indicates a reliable 5-minute VPC test. A
significant difference was found between the groups (p=.000). Domain-specific cognitive
functions were examined through other assessments, in which the 5-minute VPC test was
correlated to each of these tests. This study suggests that VPC to be a potentially reliable tool to
assess cognitive function.
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Introduction
As of January 2016 there are 46 million Americans ages 65 and older within the United
States. This number is expected to grow to over 98 million by 2060. This increase in the total
share of the population will be reflected by an increase of 15% to a staggering 24% (Mather,
Jacobsen, & Pollard, 2015). This population increase will also be associated with an increase in
age related diseases such as Alzheimer’s Disease and dementia. Dementia has been defined as a
general term for a decline in mental ability severe enough to interfere with daily life such as
severe memory loss (Alzheimers Association, 2018). Alzheimer's Disease (AD) is the most
common type of dementia that causes problems with memory, thinking, and behavior. It is
known that 75% of the cases of dementia are diagnosed as the AD. Dementia is thought to be a
progressive disease, which typically starts with mild cognitive impairment (MCI). MCI is a
syndrome defined as cognitive decline greater than that expected for an individual's age and
education level but that does not interfere notably with activities of daily life (Gauthier et al.,
2006). Prevalence of Dementia and MCI is high among older adults. 15-20% of individuals 65
years of age or older have MCI with approximately 32% of these individuals developing AD
within the next 5 years. (Jellinger & Attems, 2010; Alzheimers Association, 2018). This makes
dementia one of the most common diseases among the elderly. MCI has shown to have a high
likelihood of progression toward dementia, and as cognitive abilities worsens with time, the
presumed inevitability of institutionalization, disability, and mortality becomes more apparent.
MCI, dementia, and AD impact much more than just the individual suffering with the
disease. Families, friends, and caregivers are also affected by the large responsibility that is
accompanied with cognitive decline. Physical, emotional, and economic strain brought forth by
this disease can cause anxiety to any individual associated with this problem. This problem does
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not only strain family, friends, and caregivers but often demands support from health, social,
financial, and legal systems (World Health Organization, 2012).
One of the most influential figures that the Alzheimer’s Association published states that
early and accurate diagnosis could save 7.9 trillion dollars in medical and comprehensive care
costs. In the United States alone, every 65 seconds someone develops Alzheimer’s/dementia.
These sobering statistics indicate a clear and alarming problem. The initial area for researchers to
begin to try and solve this world wide problem needs to be establishing a functional measure to
assess cognition. Luckily, research has been conducted that exhibits an association between eye
movements and cognition levels. Until just recently, eye tracking could only be measured by
using specific and expensive equipment. It has been determined that even low resolution web
cameras, found on smartphones, tablets and computers/laptops, can track eye gaze accurately (Y.
Lin, R. Lin, Y. Lin, & Lee, 2013). This technique affords clinicians the ability to utilize common
web cameras as a tool for tracking eye movements for individuals that might be at risk for a
cognitive decline.
Changes in cognition can go unnoticed for many years; suggesting that process of a
decline of cognition begins years before a clinical diagnostic confirmation (Small, 2000). There
is not a practical and reliable approach to accurately detect cognitive changes in the early stages
of MCI or dementia. Diagnoses of dementia rely on neurological exams, brain imaging,
assessments on mental function, and reports from friends and family. The amount of energy and
effort that goes into a diagnosis of MCI or AD is extremely excessive and needs a more practical
approach. Visual paired comparison (VPC) is a validated memory recognition test with a
potential to be used for detecting memory impairments. VPC compares the amount of time an
individual fixates of on a new/novel image compared to a previously seen image when images
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are shown side by side. It can be inferred from the eye tracking data that VPC can possibly be
used as a screening tool for early dementia (Crutcher et al., 2009). It also can serve as an
assessment for detecting MCI in the early stages along with predicting the risks of an individual
developing MCI/dementia. When VPC testing is done over time, it gives the ability to monitor
changes in cognitive function.
Recently a study was completed that validated a 30-minute VPC eye tracking assessment
utilizing a built in web camera (Bott et al., 2017). One of the major drawbacks is the length of
the assessment. A shorter edition of VPC could be used as a quick and efficient screening tool
for cognitive deficiencies. A concise and accurate assessment could possibly lead to faster
cognitive screening, beneficial interventions and eventually a remedy for this plaguing disease.
Threats to Validity
Recruitment for this study primarily involved residents from a retirement home. Many
participants have similar social and economic status. This could cause a threat to validity because
of the lack of generalization when compared to the 65+ age group population. Another threat to
the validity of this study is optical problems within the participants. As age increases so does the
chances for developing eye related issues/diseases. Approximately 1 in every 3 people will
develop some form of vision reducing eye disease by the age of 65 (Ganley & Roberts 1983).
Making it an important factor when examining eye movements. Medical history questionnaires
were completed and any participant who was diagnosed with any major optical problems were
excluded from the study. Additional screening and research on vision impairments will be
critical in preserving valid results for VPC. Results for this study depend on the willingness of
participants to complete each battery to the best of their ability. If participants do not complete
the assessments to their best ability, internal validity might be threatened. Technology
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malfunctions could pose a threat to validity. Manual analysis of the VPC assessment was
conducted to establish higher accuracy of results and help negate technological malfunctions.
Limitations
The 30-minute VPC test was only be administered on the first trial, which could possibly
allow for mental fatigue to occur. The 30-minute VPC test was not be re-assessed during the
follow-up testing session. The participants that were scheduled to complete the Digit Symbol
Coding Test and NIH Toolbox test after 30-minute VPC test might have effected scores. The
crossover design used should help account for mental fatigue
Delimitations
A total of 33 subjects participated in this study. Participants reported to either the
Exercise Science Research Center at the University of Arkansas or Butterfield Trail Village.
Participants that reported to the Exercise Science Research Center will be in an isolated room
free from distractions with an administrator. Participants that reported to Butterfield Trail Village
completed all the assessments in a quiet office free from distractions. There was cognitive
assessments completed on paper, IPads, and Laptops. Trials were administered at least 14 days
apart.
Review of Literature
Cognitive impairments are not part of normal aging but do impact a substantial
population worldwide. In 2017, The World Health Organization stated that there are 50 million
people worldwide with dementia with about 10 million new cases formed every year. With the
abundance of new cases every year, this growing problem needs a resolution. Currently there is
no treatment to cure dementia or change its progressive path. Additional research, treatment, and
support could possibly help with finding a solution to this seemingly ubiquitous problem. This
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review of literature will highlight some scientific advancements with regard to assessing older
adults with unimpaired and impaired cognitive abilities. Research efforts will be the preliminary
action to cut down the major problem with screening, diagnosing, and treating cognitive decline.
One of the most widely accepted tools used for estimating the risk of dementia is the
CAIDE (cardiovascular risk factors, aging and dementia) model. CAIDE began in 1998 with the
purpose of investigating the connection between social, lifestyle, and cardiovascular risk factors
together with cognition, dementia, and structural changes in the brain. This model associates risk
factors with points. The higher number of points, then the higher the risk for developing
dementia within the next 20 years (Kivipelto et al., 2013). An abundance of research has been
conducted surrounding the CAIDE model proving it to be a useful prediction tool. A large scale
long term study was conducted to assess a diet, exercise, cognitive training, and vascular risk
monitoring intervention and its effects in cognitive decline prevention. This multi-domain
approach showed promising results that certain risk factors linked to dementia and AD could be
modified (Nganda et al., 2015). A similar study set out to determine if the results from the
previous study were reliable. Researchers determined that sociodemographic, socioeconomic
status, cognition, cardiovascular factors, and cardiovascular comorbidity did not impact the
response to the intervention group that was observed (Rosenberg et al., 2018). Thus, indicating
that their results were valid and that individuals can exhibit beneficial effects on cognition from
multi-domain interventions. This method for enhancing a healthier lifestyle can be applied to
nearly all individuals. The beneficial effects of this study were not limited by age, sex, cognitive
performance, level of education, household income, cardiovascular risk factors, or presence of
cardiovascular comorbidity. Interventions targeting beneficial lifestyle changes prove to be
useful with decreasing the potential for a cognitive decline. Suggesting that a valid and reliable
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evidence-based assessment to determine and track cognition levels used in accordance with a
lifestyle intervention could possibly impede individuals from developing cognitive impairments.
MCI is considered to be the transitional phase between standard cognitive aging and
dementia (Morris, 2012). Finding proper assessments to examine and compare cognitively intact
to cognitively impaired individuals was the first major step to evaluating these groups. One of
the first studies in this field was conducted by Daffner and colleagues (1992) in which they used
the notion that dementia patients exhibit diminished curiosity and initiative. The researchers
studied curiosity by tracking exploratory eye movements in response to visual stimuli.
Individuals with AD distributed their viewing time equally between the two images that were
shown to them. Subjects with AD spent the same amount of time on the incongruous stimuli
compared to the congruous stimuli (41.5% versus 35.5%). This differed from the cognitively
intact control, which spent more time viewing the incongruous stimuli compared to the
congruous stimuli (50.7% versus 38.4%). These results led the authors to conclude that AD
patients’ exhibit diminished curiosity that can be measured by exploratory eye movements. This
finding guided the way for more research to be conducted on the significance of eye movement
and cognition.
Years later, Visual Paired Comparison (VPC) was studied to test the potential usefulness
of predicting the onset of AD. VPC is a behavioral recognition memory task that examines the
proportion of time an individual spends viewing a novel picture compared to a previously seen
image. It has been exhibited that cognitively intact individuals concentrate their attention to
novel features (Loftus & Mackworth, 1978). Normal cognitively intact individuals spend more
time inspecting new images while, cognitively impaired individuals spend an equal amount of
time viewing a previously seen image compared to a novel image. This was showcased to be true
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in a study where eye movements were tracked when presented with novel and previously seen
images. Interestingly, with just a 2-second delay results between groups were similar. When the
delayed was lengthened to 2 minutes, MCI patients spent 53% of their time viewing the new
image compared to the control subjects who spent more than 70% of their time viewing the new
image (Crutcher et al., 2009). This finding contributed to the theory that VPC tasks can be used
as a tool to diagnose MCIs and possibly predict dementia onset. A similar study demonstrated
this to be true as well as finding that researchers could distinguish between aged matched normal
cognitive individuals and MCI subjects with 87% accuracy, 97% sensitivity, and 77% specificity
(Lagun et al., 2011). This study validated Support Vector Machines (SVM), which use an
automatic classification algorithm to determine eye gaze. This novel application detects eye
movement patterns, specific fixations, saccades, and re-fixation. In a previous study, it was
determined that cognitively intact individuals spent 10.8% of time looking at neither stimulus
while, AD patients spent 23% (Daffner et al., 1992). The time spent viewing neither stimulus
was later termed as the “grey area”. The “grey area” also incorporates the time that is spent
fixated between images, in which the SVM can also measure. This was a drastic improvement
from the best available classification system that was used at the time, which could only
distinguish individuals with a 67% accurate, 60% sensitive, and 73% specificity. Thus,
reassuring a hopeful approach for detecting cognitive impairments.
The next problem to arise was the ability to reliably differentiate individuals who are not
at risk of cognitive decline to those that are at risk. Since MCI individuals are not assured to
develop AD or dementia it is difficult to accurately assess these individuals that are at higher risk
for progressing. It has been concluded that MCI has a 6% to 25% chance of converting to AD
per year (Peterson et al., 1999). With such a high variability for cognitive decline, it is
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immensely important to determine individuals who are at risk and those who are not. Zola and
colleagues (2013), tracked elderly subjects with MCI and with unimpaired cognition for three
years. This gave the researchers to ability to monitor and test elderly individuals with VPC over
a lengthy span of time. In this study, Eight out of nine participants who exhibited a VPC score of
50 or less converted to MCI or AD but no individuals with scores of 67 or higher on VPC
converted to MCI or AD. A ROC curve was generated based on VPC scores and whether the
individual’s diagnosis worsened over three years. The ROC curve displayed area under the curve
of .903 indicating a powerful ability to discriminate between individuals who will and will not
evolve to MCI or AD. Consequently, suggesting that VPC can serve as a formidable measure for
an impending cognitive decline.
Many studies assessing the significance of VPC are using eye tracking systems that are
set up within a lab and not easily accessible to many individuals. Without eye tracking
instruments and trained technicians to properly administer VPC test, these measures would not
be possible. Finding a practical, reliable, and valid method to combat this problem was the next
step for VPC testing. A standard asset for most technological devices are built in web cameras.
Web cameras are now commonly used on desktop/laptop computers, tablets, and smartphones.
Practical alternatives to using expensive infrared eye tracking systems are warranted. It is
important to be certain that eye tracking through cameras built into smart devices can yield
correct and reliable results. A recent study assessed whether a commercially high frame rate eye
tracking camera system can be equivocally accurate to a built in web camera. The high frame
rate eye tracker showed strong associations with the web camera in regards to VPC preference
score. Along with a strong relationship on VPC preference score between the 3, 5, and 10 frames
per second that was that were assessed on the web camera. The conclusion was that the human
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scoring of the VPC strongly correlated with the automated scoring of the high frame rate eye
tracker camera during the same task (Bott et al., 2017). Interestingly throughout this study,
researchers, had significantly less data quality issues using the built in web camera. Built in web
cameras on smart devices can be highly accurate and less troublesome.
The purpose of this study was to 1) to determine the validity of the Neurotrack 5-minute
VPC test with the Neurotrack 30-minute VPC test, 2) to determine the test-retest reliability of the
Neurotrack 5-minute VPC test, 3) to compare Neurotrack 5-minute VPC scores between
individuals with cognitive impairment (Mild Cognitive Impairment and/or Alzheimer's Disease)
to cognitively intact adults, 4) lastly to compare Neurotrack VPC results with other cognitive
tasks (MoCA, NIH toolbox, Dual task) performed within the study.

Methodology
Research Design
In this study, a non-experimental, comparative research design was used. This design was
appropriate for the comparison of scores within the adult group (60+ years of age). Cognitive
assessments are compared between cognitively impaired adults and cognitively intact adults. The
independent variable for this study are the groups in which the individuals are placed
(cognitively intact group or cognitively impaired group). The dependent variables will be scores
to Neurotrack VPC assessments and other cognitive tests: Montreal Cognitive Assessment
(MoCA), Digit Symbol coding Test, NIH toolbox assessments, and Dual Task results.
Participants
All participants in this study are older adults’ age of 60+ years of age. Participants were
then divided into two subgroups which will make up the independent variables. The subgroups
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will be individuals with intact cognition and cognitively impaired individuals as determined by
the MoCA.
Measures
MoCA. MoCA is a rapid screening instrument used for mild cognitive dysfunction,
which served as an indicator for individuals for either intact or impaired cognitive abilities. This
pencil and paper assessment challenges a variance of cognitive domains: attention and
concentrations, executive functions, memory, language, visuoconstructional skills, conceptual
thinking, calculations, and orientation. The test takes approximately 10 minutes. A score of 30
possible points was obtained and if participants score ≤ 26 a guardian’s signature will be needed
before their data can be used. Scores ≤ 26 and diagnoses of AD will place participants in the
cognitively impaired group. Participants who score >26 will not need any further action for their
data to be used. One study exhibited the MoCA has a sensitivity of 83% in detecting subjects
with MCI and a sensitivity of 94% in detecting subjects with dementia (Smith, Gildeh &
Holmes, 2007).
Digit Symbol Coding Test. A pencil paper test that will serve as another cognition
assessment. This coding task will require participants to use a reference key that has digits 1-9
matched with basic symbols. They will use this reference key to manually fill in the rows of
blank spaces that are paired with a number. Participants will not be allowed to know how much
time they are allotted, just instructed to fill in the rows in order as quickly as possible. After 90
second the test will be concluded and a score will be given depending on the correct amount of
symbols they placed in the boxes. This exam challenges information processing, visual
processing and motor abilities and has been shown to be a suitable tool for cognitive impairment
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screening. This test has demonstrated acceptable values for both retest reliability and practice
effects of individual tests being >0.70 (Gonzalez-Blanch et al., 2011).
NIH toolbox. The NIHTB-CB (cognitive battery) is a comprehensive set of
measurements that can assess cognitive function from an IPad. The NIH toolbox tests will
include: Flanker Inhibitory Control and Attention test, Dimensional Change Card Sort test,
Pattern Comparison Processing Speed Test, Picture Sequence Memory Test. Before each test
there will be a trial period in which the tasks will be demonstrated. Participants will then take
part in practice sets to prove their understanding for the task. If participants are not able to
successfully complete the practice set after three attempts, they will move onto the next test. The
NIH toolbox is intended to measure neurological and behavioral function (NIH, 2017). The NIH
toolbox convergent validity for all cognitive test ranged from r = 0.48 to r = 0.93 which means
they are measuring there desired constructs (Weintraub et al., 2013).
Flanker Inhibitory Control and Attention Test. This test will display arrows pointing
in certain direction on the screen. The participants will be instructed to indicate which direction
the middle arrow is pointing. Some of the time the arrows will point the same direction and
sometimes the middle arrow will be facing the opposite direction. This will require the
participant to focus on a specific stimulus while inhibiting attention to the stimuli flanking it.
This test shows a high test-retest reliability of .96 with a convergent validity of .48 (Weintraub et
al., 2013).
Dimension Change Card Sort Change Test (DCCS). In his test participants will
Presented with two target pictures. A cue word of “shape” or “color’ will appear on the screen.
This cue word will indicate how the participant is supposed to match the images. If “shape’
appears, the participant will match by shape and if “color” appears, the participant will match by
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color. This 30-item test will help with assessing cognitive flexibility and attention. The DCCS
shows a high test-retest reliability of .94 with a convergent validity of .51 (Weintraub et al.,
2013).
Pattern Comparison Processing Speed Test. Participants will be presented with two
side by side pictures in which they will have to detect whether or not the pictures are the same or
if they differ. This is a relatively short test that takes less than 90 seconds for the participant to
finish. The picture items are simple and not too complex with hopes to solely measure processing
speed. This test shows a high test-retest reliability of .82 with a convergent validity of .49
(Weintraub et al., 2013).
Picture Sequence Memory Test. Participants will be shown a sequence of pictured
objects and images with a particular order. Once the sequence concludes, images will get
scrambled around the screen. The goal will be to replicate the sequence of pictured objects and
activities. There will be two trial consisting of one trail of 15 pictures followed by one trial of 18
pictures. There will be three novel pictures on the second trial. The intention for this test is to
assess episodic memory. This test shows a test-retest reliability of .78 and with a convergent
validity of .69 (Weintraub et al., 2013).
Visual Paired Comparison (VPC). There will be two different VPC test administered:
Neurotrack’s 30-minute VPC test and Neurotrack’s 5-minute VPC test. The 30-minute VPC test
is a passive test that requires relatively no instruction. Subjects are asked to keep relatively still
while images are displayed on a laptop computer. The 5-minute VPC test is a shortened version
that is classified as an active test because it will instruct the participants to focus on the new
image not previously seen. The web camera that is standard on the laptop computer will record
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and store the participants face and eye movements. These recorded videos will then get analyzed
by Neurotrack.
Demographics. Height and weight were assessed using a stadiometer and balance beam
scale. Height was measured to the closest 0.5 inch and weight was measured to the nearest .5 lbs.
Participants had the option of completing a body composition using a duel-energy x-ray
absorptiometry (DXA). DXA was only available at the Exercise Science Research center at the
University of Arkansas. If Participants did not use DXA, body composition was estimated with
height, weight, sex, and age.
Dual Task. This physical and mental assessment will be conducted over a length of 20
meters. It will be measured in a well-lit obstacle free location. For risk minimization participants
that would usually use assisted walking devices will asked to complete this assessment with
those devices. If participants are immobile, this portion of testing will be omitted. Timing gates
will be setup at 5 and 15 meters. Subjects will be instructed to walk a full 20 meters to ensure no
acceleration or deceleration occurred through the 5 and 15 meter timing gates. They will
complete 4 different walking tests: 20-meter walk at usual speed, 20-meter walk at usual speed
while doing a simple math problem, 20-meter walk at a fast pace, 20-meter walk at a fast pace
while doing a simple math problem. Each of these trials were completed twice. The simple math
problem is subtraction by 3 from a randomized 3-digit number. Times will be recorded to the
nearest hundredth of a second. The dual task assessment has demonstrated a reliability of >0.75	
  
(Yang et al., 2017). The aim is to determine how gait time is affected by cognitive abilities.
Dual-task test have been proven to be a valid and reliable measure to assess working memory in
older adults (Montero-Odasso et al., 2009; McCulloch et al., 2009).
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Procedures
Since IRB approval has been acquired, participants reported to either the Exercise
Science Research Center at the University of Arkansas or a continued care retirement community
in Fayetteville Arkansas. Participants reported for two separate trials at least 14 days apart. On
the first visit, participants were asked to read and review an informed consent document. Once
signed, research was able to be continued. Participants were then given a medical history
questionnaire. This was followed by the Montreal Cognitive Assessment (MoCA), which was
only assessed on the first visit. The informed consent, medical history questionnaire and MoCA
are considered to be the preliminary requirements. The order of testing was randomly selected
for all the participants and a crossover design for the two trials was used for the rest of the
dependent variables to account for mental fatigue. This means participants that completed the
Neurotrack VPC testing before the other cognitive assessments on the first trial, they then
completed the cognitive assessments first on the second trial and vice versa.
The Neurotrack VPC testing was completed on a laptop equipped with a web camera in
which individuals first completed a 30-minute test, followed by a 5-minute test. Participants only
completed the 30-minute VPC testing on their first visit and not their second. Participant’s faces
were recorded throughout the test. The video was then analyzed and eye movements were
tracked. Participants then started the next set of cognitive assessments with the Digit Symbol
Substitution Test. In which, Subjects were required to fill in a series of symbols they need to
correctly code within 90 seconds. The more symbols that were correctly coded corresponds to a
higher score and better performance.
An Ipad was involved with the NIH toolbox testing. Participants were taken through a
quick demographic questionnaire on the Ipad before completing the NIH Toolbox tests. There
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were four NIH Toolbox assessments in which they completed in the same order for both trials.
The order was Flanker Inhibitory Control and Attention Test, Dimension Change Card Sort
Change Test, Pattern Comparison Processing Speed Test and lastly the Picture Sequence
Memory Test. Before each of the assessments participants completed a practice trial to ensure
they understand their objectives. Once all NIH Toolbox tests were completed trial one was
concluded.
The second trial was done at least 14 days after the first and the preliminary requirements
were not repeated. Participants either started with the VPC testing or the additional cognitive
measures depending on the order they were completed during the first trial. After this testing was
done, additional demographic testing was then conducted on the participants. Height and weight
were assessed using a stadiometer and balance beam scale. Height was measured to the closest
0.5 inch and weight was measured to the nearest .5 lbs. Participants had the option of completing
a body composition using a duel-energy x-ray absorptiometry (DXA). DXA was only available
at the Exercise Science Research center at the University of Arkansas. If Participants did not use
DXA, body composition was estimated with height, weight, sex and age. The last cognitive
measure which was only completed on the second trial was the dual task walking test.
Participants normal and fast walking times will be measured with and without the task if simple
math problems to determine how an additional task affected gait. This concluded all of the
assessments in the study.
Data Analysis
A Pearson correlation was used to determine the validity of the 5-minute Neurotrack
VPC test compared to the 30-minute Neurotrack VPC test. The test-retest reliability of the 5minute Neurotrack VPC test was determined by a Pearson’s correlation coefficient using the data
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from the first trial compared to the second trial. To compare the 5-minute Neurotrack VPC test
scores between individuals with cognitive impairments to cognitively intact adults an Anova
repeated measures was conducted. To determine the association between VPC-5 scores with the
other cognitive tasks (MoCA, NIH Toolbox, Dual task) a Pearson correlation was used with a
statistical significance set at α = .05. Information on demographics will be presented as means ±
SD.
Results
Participants Characteristics
(Table 1) There were 33 subjects with an age of 60+ years who completed this study. 20
subjects were classified as cognitively intact (MoCA > 26), while 13 subjects were classified as
cognitively impaired by either clinically diagnosed memory problems or a MoCA < 26.
Relationship Between 5-minute and 30-minute VPC Tests
The relationship between 5-minute VPC and the 30-minute VPC revealed a positive
association. This indicates the 5-minute VPC to also be a valid measure for declarative memory.
Both the first (Table 2; r=.504; p=.006) and second (Table 3; r=.420; p=.019) time points/trials
for the 5-minute VPC revealed a significant correlation to the 30-minute VPC test.
Test Re-test Reliability of 5-minute
A paired samples T-test was used to determine the reliability of the 5-minute VPC test.
The T-test revealed no significant differences between the 2 time points/trials (p=.212). This
indicates a reliable 5-minute VPC test.
Comparing 5-minute VPC Test Between Groups
Analysis was ran on 28 subject in which 11 were cognitively impaired (mean=.687;
Std=.137) and 17 were cognitively intact (mean=.851; Std=.044). An Anova repeated measures
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analysis was used to determine any differences between the intact group and the impaired group.
Our findings indicate a significant difference between the groups (p=.000).
Associations Between 5-minute VPC Test and Cognitive Assessments
Another purpose of this study was to compare the 5 minute VPC test to other cognitive
assessments that were performed during the study. Domain-specific cognitive functions were
examined through other assessments, in which the 5-minute VPC test was correlated to each of
these tests.
On the initial day of testing (Table 2) significant relationships were not found between
any of the NIHTB-CB. The MoCA, which was only taken on day 1, exhibited a significant
relationship (r = .672; p = .000). A significant relationship was also found between the Digit
Symbol test and 5-minute VPC test (r = .643; p = .000). On the second trial (>14 days; Table 3),
significant relationships were found between the Flanker (r = .383; p = .044), PSPAC (r = .523;
p = .004), PSMT (r = .586; p = .001), While the DCCS (r = .222; p = .256) did not. The digit
symbol test(r = .750; p = .000) showed a significant relationship
Dual –Task. This assessment was only performed on trial 2, There were no significant
relationships with the DT and 5-minute VPC trial 1 testing, but there significant relationships
found on trial 2 with the 5-minute VPC testing and DT habitual speed (r = -.385; p = .029)and
DT fast pace (r = -.387; p = .031) when an simple subtraction task was involved.
Discussion
This study had four main objectives which were 1) to determine the validity of the 5minute Neurotrack VPC test with the 30-minute Neurotrack VPC test, 2) to determine the testretest reliability of the 5-minute Neurotrack VPC test, 3) to compare 5-minute Neurotrack VPC
scores between individuals with cognitive impairment (Mild Cognitive Impairment and/or
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Alzheimer's Disease) to cognitively intact adults, 4) lastly to compare Neurotrack VPC results
with other cognitive tasks (MoCA, NIH toolbox, Dual task) performed within the study.
The first purpose of determining the validity of the 5-minute and the 30-minute VPC test
revealed a moderate convergent validity between tests. Importantly, results from trial one and
trial two revealed similar correlational values. Results from the 5-minute VPC test demonstrates
a feasible alternative to the 30-minute VPC test for measuring visual recognition memory. While
both test are assessing working memory ability there are some distinguishable differences. The
30-minute VPC test has no instructions other than to look at the images on the screen. This test
was also intended to only be taken once to achieve a baseline score. The 5-minute VPC test
instructs the participants to focus on the image they have not seen before. This test should be
considered more active rather than passive because of the basic qualities of the test. Furthermore,
the active nature of this test reveals a significant benefit in which it can be taken repeatedly over
time.
The second primary objective was to determine the test re-test reliability of the 5-minute
VPC. The results revealed no statistical differences between the two time points. This signifies a
strong test-re-test reliability of the 5-minute VPC test. Test re-test reliability ensures that
individuals can take this assessment repeatedly over time without significant differences in
cognitive scores.
The third purpose of this study was to compare the 5-minute VPC scores with the
cognitively intact group and the cognitively impaired group. Statistics revealed a significant
difference between the intact and the impaired groups. The 5-minute VPC test was able to
determine differences and differentiate individuals who were classified as cognitively intact and
cognitively impaired. Additionally, there were no significant differences found within the groups
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indicating similar results within the two groups. Thus showing additional reliability for the 5minute VPC test.
The last purpose of the study was to compare the 5-minute VPC scores to the other
cognitive assessments performed. The 5-minute VPC test had more significant correlations with
cognitive batteries that were performed on second trial day. Three out of four NIHTB-CB test
were significantly correlated (Flanker, PSPAC, and PSMT) on day 14 while none of the NIHTBCB were correlated with trial 1 testing. This possibly indicates some testing effects which can
occur when tasks are repetitively practiced and results are changed or improved. The NIHTB-CB
only have one version of each of the test and were repeated on both trial days. This repetitive
testing for cognitive batteries has been proven to make assessments vulnerable to learning/testing
effects and unlikely that these changes are associated to changes in cognitive abilities (Goldberg
et al., 2015). Additional practice trials on the NIHTB-CB could possibly mitigate some of these
testing effects for future studies. Advantageously, Testing effects are alleviated in the 5-minute
VPC tests because of the substituted forms that were used on trial one and trial two.
A limitation displayed in this study was data quality issues from the VPC testing. The
data quality issues included glare from glasses, electronic errors, and low lighting. Results were
excluded from one older adult for the 30-minute VPC test, five older adults for the 5-minute
VPC testing Trial 1, and one older adult for the 5-minute VPC testing Trial 2. The rest of the
batteries that were performed by these participants were still included in the assessments because
of the completion of both trials. Ecological validity was also a limitation of this study. Testing
was done in a research setting which either included a private office or a secluded room instead
of participants natural settings such as their home. Moreover, research needed to be conducted in
these setting to ensure quality data collection and compliance from participants. Lastly, a small
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amount of cognitively impaired individuals participated in the study. Future studies should
include more cognitively impaired individuals to increase the ability assess different levels of
impairment.
The 5-minute VPC test from Neurotrack shared many significant associations to other
gold standard cognitive assessments. There are also beneficial differences that the 5-minute VPC
test has exhibited such as scalability. Other assessments have been proven to be valid and
reliable but need to be taken in person and with a trained professional. Instead of having to rely
on trained professionals to administer cognitive exams, individuals can administer this
assessment solely on their own. The alternate forms that are available in the 5-minute VPC test
also allows for individuals to retake the assessment to track any cognitive changes. Yet another
upside to the 5-minute VPC test is that individuals can take this examination anywhere that has
internet connection and a smart device that has a camera built-in or attached.
In conclusion, this study exhibited moderate convergent validity between the 5-minute
VPC and 30-minute VPC assessments. A strong test re-test reliability of the 5-minute VPC test
was revealed. Significant differences were found between the cognitively intact and cognitively
impaired groups and significant correlations were found between the 5-minute VPC test and
other cognitive assessments. Results indicate a hopeful approach to screen and monitor cognitive
health over time. The 5-minute VPC test is not intended to be a diagnostic test which would
require additional research with larger samples of participants. Future studies should be done to
examine effects of testing in common environments instead of isolated and unfamiliar places.
Because of the minimal recruitment of cognitively impaired individuals in this study more
research still needs to be conducted on cognitively impaired populations.
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Appendices
Tables
Table 1. Characteristics of the study cohort
Average age (SD)
Sex
Female
Education
High School Graduate
Some College
College graduates or higher
Race
European-American
Other
Biometric
Height (SD)
Weight (SD)
Cognitively Normal
Cognitively Impaired

	
  

Older Adults (n = 33)
78.2 years
(6.9)
72.7%
6.1%
15.2%
78.7%
97%
3%
164.7 cm (10.3)
71.3 kg (13.8)
66.7%
33.3%

